Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (541-550 of 663) with videos related to

Pageof 67
Sort By:
European Journal of Heart Failure|August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failureWillem J Remme, John G Cleland, Leif Erhardt, et al.
Journal of the American College of Cardiology|May 2, 2009
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillationRobby Nieuwlaat, Luc W Eurlings, John G Cleland, et al.
Pharmacological Research|June 6, 2022
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal diseaseP Rossignol, J Silva-Cardoso, M N Kosiborod, et al.
The Journal of Rheumatology|July 17, 2016
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis CohortNasir T Wabe, Michael J Sorich, Mihir D Wechalekar, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1979
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological featuresB M Greenwood, A K Bradley, P G Cleland, et al.
Seminars in Arthritis and Rheumatism|March 30, 2007
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useSusanna M Proudman, Helen I Keen, Lisa K Stamp, et al.
Heart (British Cardiac Society)|September 9, 2011
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge periodMatthew E Harinstein, James D Flaherty, Gregg C Fonarow, et al.
European Journal of Heart Failure|March 28, 2020
Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHFIfy R Mordi, Wouter Ouwerkerk, Stefan D Anker, et al.
JACC. Heart Failure|June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Pageof 67

Showing results (541-550 of 663) with videos related to

Sort By:
Pageof 67
European Journal of Heart Failure|August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failureWillem J Remme, John G Cleland, Leif Erhardt, et al.
Journal of the American College of Cardiology|May 2, 2009
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillationRobby Nieuwlaat, Luc W Eurlings, John G Cleland, et al.
Pharmacological Research|June 6, 2022
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal diseaseP Rossignol, J Silva-Cardoso, M N Kosiborod, et al.
The Journal of Rheumatology|July 17, 2016
Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis CohortNasir T Wabe, Michael J Sorich, Mihir D Wechalekar, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1979
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological featuresB M Greenwood, A K Bradley, P G Cleland, et al.
Seminars in Arthritis and Rheumatism|March 30, 2007
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useSusanna M Proudman, Helen I Keen, Lisa K Stamp, et al.
Heart (British Cardiac Society)|September 9, 2011
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge periodMatthew E Harinstein, James D Flaherty, Gregg C Fonarow, et al.
European Journal of Heart Failure|March 28, 2020
Heart failure treatment up-titration and outcome and age: an analysis of BIOSTAT-CHFIfy R Mordi, Wouter Ouwerkerk, Stefan D Anker, et al.
JACC. Heart Failure|June 23, 2014
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Pageof 67